SS18L2: A Potential Drug Target and Biomarker (G51188)

Target Name: SS18L2

NCBI ID: G51188

SS18L2

SS18L2: A Potential Drug Target and Biomarker

SS18L2 (S18L2_HUMAN) is a protein that is expressed in various tissues of the human body, including the liver, pancreas, and muscle. It is a member of the S18 family of proteins, which are involved in various cellular processes, including cell signaling, DNA replication, and protein synthesis.

SS18L2 is unique because of its ability to interact with other proteins, both in the S18 family and outside of it. This interactivity has led some researchers to consider SS18L2 as a potential drug target or biomarker.

One of the reasons why SS18L2 is considered a drug target is its role in the development and progression of certain diseases. For example, studies have shown that SS18L2 is highly expressed in pancreatic cancer, and that it is associated with poor prognosis in patients with pancreatic cancer. Additionally, SS18L2 has been shown to be involved in the development of certain neurological conditions, such as Alzheimer's disease and Parkinson's disease.

Another reason why SS18L2 is considered a potential drug target is its role in the regulation of cellular processes. For example, studies have shown that SS18L2 is involved in the regulation of cell growth, cell cycle progression, and protein synthesis. Additionally, SS18L2 has been shown to play a role in the regulation of cellular signaling pathways, including the TGF-β pathway.

SS18L2 is also considered a potential biomarker because of its ability to be targeted by small molecules. This has led some researchers to consider SS18L2 as a potential drug or therapy for a variety of conditions, including cancer, neurodegenerative diseases, and autoimmune disorders.

In conclusion, SS18L2 is a protein that is expressed in various tissues of the human body and is involved in a variety of cellular processes. Its interactivity with other proteins and its ability to be targeted by small molecules make it a promising target for drug development and research into the underlying mechanisms of various diseases. Further research is needed to fully understand the role of SS18L2 in the development and progression of disease, as well as its potential as a drug target or biomarker.

Protein Name: SS18 Like 2

The "SS18L2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SS18L2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets